Stasinos Chr. Sikalias · The science of compounding

Salicylic oil 5% without ethanol PO004

CGR-ES-062 · FN/2003/PO/004 ACEITE SALICILADO SIN ALCOHOL

For local reviewCGR-ES-062Spain · AEMPS

WORKSHEET FOR LOCAL APPROVAL — source authority does not replace batch approval.

Dosage formCutaneous solution
Reference batch100 g
Monograph version4.0
Source packagev4

Source formula

IngredientSource quantity
Salicylic acid5 g
Virgin castor oil50 g
Virgin olive oilq.s. ad 100 g

Quantities refer to the source batch. This website does not automatically scale formulas, assign doses or calculate BUD.

Description

Documented in source

Transparent yellow-green oily solution.

References: [1]

Use and action

Documented in source

Hyperkeratotic scalp lesions in seborrhoeic dermatitis/psoriasis according to the source.

References: [1]

Specifications

Documented in source

Transparent yellow-green oily solution.

References: [1]

Light

Partial evidence

Protect virgin castor oil from light.
Protect virgin olive oil from light.
For the finished product the source specifies:
Amber bottle, protect from light/moisture, <25°C.

References: [1] · [2] · [3]

Air

Partial evidence

Castor oil can undergo oxidative rancidity.
Virgin olive oil is oxidisable; store the raw material in a full, well-closed container.

References: [2] · [3]

Water and solubility

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Humidity

Partial evidence

For the finished product the source specifies:
Amber bottle, protect from light/moisture, <25°C.

References: [1]

Temperature

Partial evidence

Virgin castor oil raw material: ≤25°C in PA031. The formula separately specifies processing temperature.
Virgin olive oil raw material: ≤25°C. This storage limit does not change the specific formula’s processing temperatures.
For the finished product the source specifies:
Amber bottle, protect from light/moisture, <25°C.

References: [1] · [2] · [3]

pH and related incompatibilities

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Other incompatibilities

Partial evidence

Salicylic acid: incompatibilities with alkalis, Fe/Pb salts and iodine. Above 2%, problems may occur in nonionic emulsions.

References: [4]

Ingredient-specific information

Partial evidence

Salicylic acid: Salicylic acid: incompatibilities with alkalis, Fe/Pb salts and iodine. Above 2%, problems may occur in nonionic emulsions.
Virgin castor oil: Castor oil can undergo oxidative rancidity.
Virgin olive oil: Virgin olive oil is oxidisable; store the raw material in a full, well-closed container.
These are selected facts for identified ingredients; relevant sensitivities and incompatibilities are detailed in the corresponding fields. This is not a complete SDS for every material.

References: [2] · [3] · [4]

Personal protective equipment

Partial evidence

Salicylic acid: avoid dust, inhalation and eye/mucosal contact; use eye protection.
Supplementary AEMPS framework: clean long-sleeved laboratory clothing, hair covering and dedicated footwear/overshoes. Powder handling requires suitable eye/respiratory protection; change gloves with activity or damage. Select the exact type/material using SDS and risk assessment.

References: [4] · [5]

Risks and precautions

Partial evidence

A complete formula-specific hazard classification is not established. Assess potency, dust/aerosol, allergens, solvents, microbial risk and cross-contamination using the actual materials and process. Absence of a flag does not establish absence of hazard.

References: [1]

Compounding conditions

Documented in source

The corresponding AEMPS SOP specifies room temperature 25 ± 5°C and relative humidity ≤60%, unless the particular formula requires otherwise. This is the work environment, not processing or storage temperature.
Follow the addition sequence, temperatures and times stated under Preparation Procedure. The specific monograph is not a complete qualification of the local facility/equipment.

References: [1] · [6]

BUD rationale

Documented in source

3 months under the source conditions.
The source period applies to its exact composition, method and packaging. It is not this batch’s expiry date and cannot be transferred to another vehicle/strength. Calculate the actual date in the blank batch record.

References: [1]

Bases and dependencies

Partial evidence

No separate base is identified in the dependency register. Check any commercial vehicles/compound excipients listed in the formula.

References: [1]

Equipment

Editorial checklist

Indicative checklist derived from the method: Balance of suitable resolution, Containers and mixing tools compatible with the materials, Mortar and pestle, Controlled heating and thermometer. Selection/qualification is defined locally.

References: [1]

Preparation procedure

Documented in source

Triturate salicylic acid if necessary. Dissolve in castor oil in a water bath at about 50°C. Add olive oil, homogenise by stirring and cool.

References: [1] · [6]

Observations

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Packaging

Documented in source

Amber bottle, protect from light/moisture, <25°C.

References: [1]

Quality control

Partial evidence

Transparent yellow-green oily solution.
Additional tests from the referenced SOP:
Appearance and mass/volume. For batches: colour, clarity/opalescence, relative density, pH and microbiological testing RFE 5.1.4.
pH under PN/CP/001: normally test the untreated sample unless otherwise specified. Accurate measurement follows potentiometric RFE 2.2.3; strips are limited to checks not requiring high accuracy.

References: [1] · [6] · [7]

Storage

Documented in source

Amber bottle, protect from light/moisture, <25°C.

References: [1]

Dispensing and directions

Documented in source

Not for salicylate allergy or under 2 years. Avoid eyes/mucosa and occlusion without medical direction. The source directs night application and removal in the morning with mild shampoo. Check concurrent salicylates/keratolytics.

References: [1]

Labelling

editorial_specimen

Salicylic oil 5% without ethanol PO004
Strength/variant: __________ Quantity: __________
Batch: __________ Prepared: __________ Use by: __________
Εξωτερική χρήση / External use
Dose/directions: __________
Storage: Amber bottle, protect from light/moisture, <25°C.
Not for salicylate allergy or under 2 years. Avoid eyes/mucosa and occlusion without medical direction. The source directs night application and removal in the morning with mild shampoo. Check concurrent salicylates/keratolytics.

References: [1]

Sources and traceability

  1. FN/2003/PO/004 ACEITE SALICILADO SIN ALCOHOL

    FN/2003 • ηλεκτρονικό κείμενο με NIPO 2020/2022 / electronic text with NIPO 2020/2022 · PDF pp. 2–4 · A1

    Review date reported in supplied metadata: 2026-09-10

  2. FN/2003/PA/031 RICINO, ACEITE VIRGEN DE

    Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–2 · A1

    Review date reported in supplied metadata: 2026-09-10

  3. FN/2003/PA/027 OLIVA, ACEITE VIRGEN DE

    Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–2 · A1

    Review date reported in supplied metadata: 2026-09-10

  4. FN/2003/PA/033 SALICÍLICO, ÁCIDO

    Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–2 · A1

    Review date reported in supplied metadata: 2026-09-10

  5. PN/L/PG/002/00 INDUMENTARIA

    Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–5 · A1

    Review date reported in supplied metadata: 2026-09-10

  6. PN/L/FF/007/00 ELABORACIÓN DE SOLUCIONES

    Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–6 · A1

    Review date reported in supplied metadata: 2026-09-10

  7. PN/L/CP/001/00 DETERMINACIÓN DE PH

    Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–5 · A1

    Review date reported in supplied metadata: 2026-09-10

Provenance and reuse

This record comes from the supplied v4 collection. Primary-source rights and licences remain separate. No new comprehensive licence review has been performed for the earlier 239 records.

SHA-256 of the supplied PDF: dc21dcc9e5a2f2dedacc4b30089ce85360aa4167035f317c8b7aa2b72e3a6788